10% to 15% of lung cancers are small-cell lung cancers. Lung cancer can cure with treatments like chemotherapy. Radiotherapy is not severe compared to non-small cell lung cancer [5].

About 85% of Lung cancers are non-small cell lung cancers [6]. Small cell lung cancer is the most frequent type of lung cancer, and it further includes four subtypes.

1) Adenocarcinomas

2) Squamous cell carcinoma

3) Small cell carcinoma

4) Large cell carcinoma

Adenocarcinomas are peripheral masses that spread into the body in the form of Metastasis. Patients suffering from lung diseases are likely to get affected by this [7]. Squamous cell carcinomas are masses present in bronchi. These metastasize slowly. Small cell carcinomas are centrally located and clinically hostile. Large cell carcinomas are difficult to identify and are large peripheral masses [8].

Smoking is one of the primary risk factors for lung cancer. The mortality rate increased at the beginning of the 20^th century due to the overconsumption of tobacco, and smoke.

Released from tobacco contains toxic substances, carcinogens, and many harmful chemicals. Calculation of the smoking intensity is by the number of years and cigarettes smoked per day [9].

The smoke of cigarettes contains nicotine in which. It got a patent in 1965. It became popular by 2003 and was almost available everywhere in 2005. There are 460 brands and 7700 flavors. Adults between 12 to 18 widely use these. In the USA, a survey done by national youth in 2017 reported that 20.8% of high school students and 4.9% of middle school students highly use e-cigarettes [10]. Studies show that vapor generated from e-cigarettes is harmful and shows long-term effects. But data suggests that e-cigarettes are less harmful than regular cigarettes [11].

The cause of five to ten percent of lung cancer is occupational exposure to natural asbestos in rocks like altered ultramafic and mafic rocks. International Agency for Research on Cancer reported that occupational exposure. [12] includes exposure to chromium, arsenic, and cadmium. Studies conducted on people in Canada and Europe conclude that there is a rise in the risk of asbestos exposure by 12% in women and 24% in men [13].

Intake of foods that are rich sources of antioxidants, nutrients, and vitamins might decrease the cancer risk, but some studies proved that a high intake of antioxidants and Carotenoids, Preservation of Meat in salt like Sausages, pork, and Deep-fried recipes proved that these might increase the possibilities of lung cancer.

A study conducted on 399, 767 people and 3137 lung cancer patients showed high alcohol consumption.

Cannabis is the most common drug used other than tobacco. Approximately 7000 new people per day are smoking cannabis. The international lung cancer consortium conducted surveys on 2159 patients. They reported a slight indication that the effects of cannabis might be long-term [14]. Cannabis contains the same toxic chemicals that are present in tobacco.

Radon has no taste, odor, and color. It is a radioactive gas obtained from soil and generated during the nuclear disintegration of uranium and thorium [15]. The next most common cause of lung cancer is Radon exposure in the United States. Because of radon gas, 3% to 14% of lung cancer patients are affected. However, we all believe radon mainly causes it, but it depends on the population [16].

HIV is related to lung cancer. It is the most common death cause of cancer people [17]. Adults infected with HIV are more likely to smoke cigarettes than others. Studies also revealed that treatment for HIV may often reduce cancer risk.

25% of lung cancer patients in the world are nonsmokers [18]. Among them, 60% to 80% are females. Risk factors correlated with nonsmokers are cooking fumes, radon gas, and Hereditary. The cancer risk for nonsmokers has significantly increased over the decades [19]. Diagnosis: Diagnosis of Lung cancer by Weight loss, fatigue, cough, and chest pain. Diagnosis of lung cancer in the early-stage results in a high Survival rate and require high care by physicians even though they do not show any symptoms [20] (Table 1).

Reference: [16].

Generally, the Usage of CT scans to diagnose Lung cancer. There are several ways for tissue evaluation like bronchoscopy, thoracentesis, and mediastinoscopy. The minimal, confined approach is to choose the highest yield method. EBUS-TBNA is the most used method for central tumors in the body. They gave tissue diagnoses to patients suffering from non-small cell lung cancer. There are many ways lung cancer occurs when disease severity is less [21] [22]. Some include flexible bronchoscopy, sputum cytology, and thoracic needle aspiration. Sputum cytology is to detect centrally located tumors in the body. It notices 71% of central and 50% of peripheral tumors. Using flexible bronchoscopy is to see 88% of central tumors. Bleeding and pneumothorax are severe injuries of transbronchial needle aspiration [23]. Transthoracic needle aspiration seems to be effective compared to bronchoscopy. The most challenging part of this is the insertion of the needle into the chest tube. Video-assisted thoracoscopy is to detect small peripheral tumors [24].

Surgery is not suitable for all patients. It is only recommended for patients with stage One to stage Three A. Surgery is one of the best methods to cure lung cancer. But for surgery, the patient must agree to the intervention of surgery. Recently, changes to surgical eligibility, including lobectomy [17] [25]. In the beginning, many surgeries focused on increasing the selection criteria for surgical incisions of lung cancer in people on the edge of operation [26].

Initially, verification of writings on whether lobectomy is needed or not for minor lumps [27] does not have proof due to combined reports. Most of them are from little reminiscence series, and the lobectomy method will be the primary standard method for the surgical department of NSCLC.

Changing cell signaling and regulatory pathways that pathways can inactivate, resulting in lung cancer treatment. So, this kind of method is in receptor tyrosine kinases. Most of the patients are with inactivated NSCLS and EGFR carrying. There advanced many different EGFR inhibitors long ago. Gefitinib is the first lung cancer drug that FDA approved. However, during phase 3 clinical trials, Gefitinib failed to report the endurance of their drug test.

Almost 10% - 30% of tumors activate the tyrosine kinase domain in the EGFR gene. Osimertinib is the 3^rd generation EGFR TKI in front-line therapy. Based on the research studies, contrast Osimertinib with the first-generation Patients with EFGR TKI who developed a superior median OS of Osimertinib for 38.6 months.

Patients with significant lung cancers are present at the time of treatment. The primary use of chemotherapy is for patients whose disease is advanced [28] —treatment of Stages from IIA through IIIA NSCLC patients with adjuvant chemotherapy. Typically, chemotherapy is pretty much better for lung cancer patients. However, still, there is an insight thought about using the standard traditional therapeutic agents [29]. All these years, there has been an increase in cancer biology studies. These studies have opened several helpful therapeutic strategies, including EGFR, Signal transduction, and Angiogenesis pathways. Certain lung cancer patients with high-risk diseases might have a chance to welcome back the condition. In 1995 an excellent data analysis took place on 52 different patients in the clinical trials and compared the results after the surgery; in this analysis, a 5-year-old who lived through the chemotherapy saw significant results because he received platinum-based chemotherapy.

One thousand eight hundred sixty-seven subjects enrolled in international adjuvant lung cancer trials, and these patients are from Stage One to Stage Three cancer. Besides, these different patients also receive platinum-based chemotherapy [30]. Under observation for five years, relic advantage was 4.1%, and the chance of dying went down to 14%. Four hundred eighty-two subjects in Stage Two cancer from Stage One got enrolled in the national cancer institute of Canada and inter-group study.

The veteran’s administration of lung cancer study group conducted the first radiation therapy clinical trial for lung cancer patients. This study group has segregated the patients regarding small cell and extensive cell diagnoses usually given to receive a thoracic artery [31]. Hadron is a minute particle affected by nuclear force. These hadrons carry major biologic validness and can quickly transfer their energy where there is low oxygen. However, the main problem with this Hadron therapy is that it is costly with the systemic network. Nevertheless, many things have helped patients survive lung cancer, which are nothing but cell differentiation, maintaining a proper diet, changing the markers of molecules, and quitting smoking. There is a hospital with 5018 beds with 712 patients. On top of that, these patients survived due to the changes in age, treatment type, and quitting smoking.

Many lung cancers can be easily avoided by quitting smoking. Since 1960, the smoking people ratio has been slightly reduced. In 2016 United States government conducted a survey, and in the survey, they came to know that 50.5% of smoking cigarettes came from adults. Even though many smoking companies have mentioned that smoking is harmful to health and can cause cancer and death [36]. Early findings are the only choice to find people suffering very highly. Globally, lung cancer will be the most significant health problem in this 21^st century due to its rapid advances in diagnosis, risk assessment, and early detection. Treatment will be critical and prevent advances in disease.

These play a significant part in the process of lung cancer. Autophagy is also called self-eating. This late endosome is present in autophagy. Alternatively, it can be either shifted or merged with the lysosome to produce autolysosome.

Apoptosis is otherwise known as cell death. Intracellular or extracellular signals are prominent by a morphological change in cell death. Autophagy can function as positive and negative in encouraging apoptosis in non-small cell lung cancer. Autophagy and apoptosis get alerted under the stress of cells. Generally, autophagy leads to apoptosis, supporting the homeostasis of cells.

Many results show that autophagy is also called Autophagic cell death. The deficiency of chromatin condensation identifies it. LC3 Lipidation and independent apoptosis by inhibiting the pathway of autophagy or autophagy genes.

ADC contains several methods of cell death. The caspases and apoptotic processes of autophagy-related proteins are part of cell death. Recent studies proved that caspases play a role in autophagy regulation. The activated caspases prevent autophagy, in which caspases collapse the proteins that are associated with autophagy. For example, caspase eight is popularly known for preventing pro-autophagy. Inhibition of caspase eight results in hyperactive autophagy of T cells. Whereas Caspase 9 is a protein related to the production of the apoptosome and apoptotic pathways intrinsic. It represents those caspases that are activated execute synonyms as well as strengthen autophagy [37].

The exponential growth of selected remedies with a progressive and robust group of drugs and portrayal of the mechanism of obtained resistivity confirmed the character for repeated genomic profiling during Tumor development, mainly in cases with EGFR mutations. T790M, the most common root of resistance, is fortunately treated with Osimertinib. The continuous study of the Genomic index is carried out by numerous biopsies. It leads to many complications. The alternative is to utilize plasma genotyping along with sequencing circulating tumor DNA. The study conducted on 216 patients with plasma genotyping and central tissue showed 70% of plasma genotyping. Tissue negative results patients identified with 31% plasma EGFR mutations. The reason was that the medication of Osimertinib and ORR and PFS resulted in equal T790M. Treatment of continuous biopsy for patients with negative plasma results. Due to rare gene alterations, applying many types of research on non-small cell lung cancer is problematic. Enrolling patients to conduct studies has become difficult. So innovative master protocols are invented to check this issue [38].